Clene Inc. (CLNN) income statement
CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.42+0.20 (+6.21%)
Close on Nov 18, 2026Market cap $43.94MP/E –Yield –
Clene Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 70.1%
- Operating margin
- -10432.0%
- Net margin
- -20059.9%
- Return on equity, FY2025
- 197.9%
Financial strength
- Current ratio
- 3.07
- Debt to equity
- -0.22
- Debt to assets
- 23.3%
- Cash to current liabilities
- 199.3%
Valuation
- P/E ratio
- –
- Price to sales
- 223.06
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?